{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:48:46Z","timestamp":1789674526456,"version":"4.0.1"},"reference-count":29,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1136\/jnnp-2013-304897","type":"journal-article","created":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T20:36:18Z","timestamp":1366403778000},"page":"1068-1074","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":96,"title":["Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients"],"prefix":"10.1136","volume":"84","author":[{"given":"Stefanie","family":"Dahlhaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hoepner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Kleiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ortwin","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Hellwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,4,19]]},"reference":[{"key":"key-10.1136\/jnnp-2013-304897-1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard.2006.058404","article-title":"Natalizumab and progressive multifocal leukoencephalopathy","volume":"65","author":"Berger","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"key-10.1136\/jnnp-2013-304897-2","first-page":"93","article-title":"Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgki\u0144s disease","volume":"81","author":"Astrom","year":"1958","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2013-304897-3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(59)91774-X","article-title":"Cerebral demyelination associated with disorders of the reticuloendothelial system","volume":"2","author":"Cavanagh","year":"1959","journal-title":"Lancet"},{"key":"key-10.1136\/jnnp-2013-304897-4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00005072-196210000-00001","article-title":"Infectious leukoencephalitis. A critical comparison of certain experimental and naturally-occurring viral leukoencephalitides with experimental allergic encephalomyelitis","volume":"21","author":"Waksman","year":"1962","journal-title":"J Neuropathol Exp Neurol"},{"key":"key-10.1136\/jnnp-2013-304897-5","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1126\/science.148.3676.1477","article-title":"Particles resembling papova viruses in human cerebral demyelinating disease","volume":"148","author":"Zu Rhein","year":"1965","journal-title":"Science"},{"key":"key-10.1136\/jnnp-2013-304897-6","first-page":"1257","article-title":"Cultivation of the papova-like virus from human brain with progressive multifocal leucoencephalopathy","volume":"1","author":"Padhett","year":"1971","journal-title":"Lancet"},{"key":"key-10.1136\/jnnp-2013-304897-7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF01997713","article-title":"Progressive multifocal leucoencephalopathy","volume":"17","author":"Dalsgaard Hansen","year":"1996","journal-title":"Ital J Neurol Sci"},{"key":"key-10.1136\/jnnp-2013-304897-8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jmv.10450","article-title":"Population-based study of antibody to the human polyomaviruses BKV and JCV and the semian polyomavirus SV 40","volume":"71","author":"Knowles","year":"2003","journal-title":"J Med Virol"},{"key":"key-10.1136\/jnnp-2013-304897-9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa044396","article-title":"Natalizumab plus Interferon beta-1a for Relapsing Multiple Sclerosis","volume":"354","author":"Rudick","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2013-304897-10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMoa051782","article-title":"Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis","volume":"353","author":"Kleinschmidt-DeMasters","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2013-304897-11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","article-title":"Progressive multifocal leukoencephalopathy in a patient treated with natalizumab","volume":"353","author":"Langer-Gould","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2013-304897-12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa051586","article-title":"Progressive multifocal leukoencephalopathy after natalizumab therapy for Croh\u0144s disease","volume":"353","author":"Van Assche","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2013-304897-13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","article-title":"Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis","volume":"9","author":"Tan","year":"2010","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2013-304897-14","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMoa0810257","article-title":"Treatment of progressive multifocal leukoencephalopathy associated with natalizumab","volume":"361","author":"Wenning","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2013-304897-15","first-page":"196","volume-title":"The clinical evaluation of chemotherapeutic agents in cancer","author":"Karnofsky","year":"1949"},{"key":"key-10.1136\/jnnp-2013-304897-16","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0b013e3182583022","article-title":"Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort","volume":"78","author":"Trampe","year":"2012","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2013-304897-17","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1212\/WNL.0b013e31822e55e7","article-title":"Immune reconstitution inflammatory syndrome in natalizumab-associated PML","volume":"77","author":"Tan","year":"2011","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2013-304897-18","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"366","author":"Bloomgreen","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2013-304897-19","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/archneurol.2010.157","article-title":"Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis","volume":"67","author":"Schr\u00f6der","year":"2010","journal-title":"Arch Neurol"},{"key":"key-10.1136\/jnnp-2013-304897-20","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/jnnp-2012-302478","article-title":"Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies","volume":"83","author":"Mentzer","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2013-304897-21","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1128\/AAC.01614-08","article-title":"Identification and characterization of mefloquine efficacy against JC virus in vitro","volume":"53","author":"Brickelmaier","year":"2009","journal-title":"Antimicrob Agents Chemither"},{"key":"key-10.1136\/jnnp-2013-304897-22","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1103492","article-title":"The human polyomavirus, JCV, uses serotonin receptors to infect cells","volume":"306","author":"Elphick","year":"2004","journal-title":"Science"},{"key":"key-10.1136\/jnnp-2013-304897-23","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1212\/WNL.0b013e31820b7644","article-title":"Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS","volume":"75","author":"Vennegoor","year":"2011","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2013-304897-24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00019052-200406000-00019","article-title":"New insights into progressive multifocal leukoencephalopathy","volume":"17","author":"Koralnik","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"key-10.1136\/jnnp-2013-304897-25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1086\/595299","article-title":"Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study","volume":"199","author":"Engsig","year":"2009","journal-title":"J Infect Dis"},{"key":"key-10.1136\/jnnp-2013-304897-26","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s00147-004-0779-3","article-title":"Progressive multifocal leukoencephalopathy in transplant recipients","volume":"17","author":"Shitrit","year":"2005","journal-title":"Transpl Int"},{"key":"key-10.1136\/jnnp-2013-304897-27","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1212\/WNL.0b013e31821a446b","article-title":"Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"76","author":"Vermersch","year":"2011","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2013-304897-28","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.20858","article-title":"Immune surveillance in multiple sclerosis patients treated with natalizumab","volume":"59","author":"St\u00fcve","year":"2006","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2013-304897-29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1212\/01.wnl.0000194227.16696.11","article-title":"Seizures and their outcome in progressive multifocal leukoencephalopathy","volume":"66","author":"Lima","year":"2006","journal-title":"Neurology"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2013-304897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T13:52:07Z","timestamp":1601041927000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2013-304897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,19]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,9,2]]},"published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.1136\/jnnp-2013-304897"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2013-304897","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718063964.793481849","asserted-by":"object"}]},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,19]]}}}